Sponsors (2)
The bill sharply reduces future asbestos-related health risks by banning commercial asbestos while balancing continuity of critical industrial and national-security operations through time-limited carve-outs and exemptions—trading faster health protections for temporary exposure extensions and near-term economic compliance costs.
Patients, healthcare workers, and building occupants will face lower lifetime risk of asbestos-related disease because the bill bans manufacture, processing, use, and distribution of commercial asbestos (targeting eight asbestiform minerals), preventing new asbestos-containing products from entering commerce.
Chlor-alkali facilities that are operating on enactment can continue using asbestos diaphragms until 1/1/2030, avoiding immediate shutdowns, supply interruptions, and sudden job losses in affected plants.
Federal national-security needs can be met during transitions because the bill creates a narrow presidential exemption process (with conditions intended to minimize exposure), allowing temporary continued asbestos use to avoid abrupt disruptions to critical operations.
Workers at chlor-alkali facilities and nearby communities (and other populations covered by exemptions) will face prolonged asbestos exposure because the bill allows continued use in existing chlor-alkali plants until 2030 and permits presidential exemptions that can extend use for additional years.
Companies that rely on asbestos in products must stop manufacturing or otherwise comply immediately, creating near-term compliance costs, potential layoffs, and business disruption for affected manufacturers and their workers.
Public transparency and oversight will be reduced because the law permits withholding publication in the Federal Register for national-security exemptions, limiting public knowledge and external review of continued asbestos use.
Based on analysis of 2 sections of legislative text.
Immediately bans manufacture, processing, use, or distribution in commerce of defined commercial asbestos and products containing it, with limited carve‑outs and a narrow national‑security exemption process.
Introduced September 16, 2025 by Suzanne Bonamici · Last progress September 16, 2025
Bans the manufacture, processing, use, and distribution in commerce of defined “commercial asbestos” and products containing it effective immediately, while carving out a time-limited allowance for existing chlor‑alkali facilities to continue specified uses until January 1, 2030. Sets a narrowly tailored presidential national‑security exemption process (initial term up to 3 years, one extension up to 3 years) with required exposure‑minimizing terms and Federal Register publication rules, and prevents EPA from invoking a separate waiver authority for commercial asbestos.